Partner Magazine logo 14

ABOUT CAMLOG 20 THE RESEARCH TEAM INTRODUCES ITSELF THE TEAM IS INVOLVED IN RESEARCH FOR THE BENEFIT OF OUR CUSTOMERS AND THEIR PATIENTS The CAMLOG research department is located at the headquarters in Basel and is led by Dr. Alex Schär, Chief Technology Of cer. The small team of highly quali ed interdisciplinary specialists looks after the aspects of pre-clinical and clinical research, the assessment of new technologies in the eld of materials and surfaces, as well as brands, patents and the names of domains. As a department, we are always dedicated on focusing our activities on the best possible quality and best possible clinical results for the bene t of our customers and the patients treated with CAMLOG products. The CAMLOG research team The research team combines a broad spec- trum of knowledge and over 60 years of experience in the research and develop- ment of medical devices. Dr. Alex Schär studied electrical engineering and bio- engineering in Switzerland, the USA and Scotland and graduated in the eld of biomechanics. He has been involved in the eld of research and development of oral implants for over 20 years. Françoise Peters, Head of Clinical Research, acquired her extensive knowledge on clini- cal research in the pharmaceutical indus- try and has spent over 20 years working for companies involved in oral implantol- ogy. She graduated in business manage- ment and has a Master in Public Health. Peter Thommen, scientist with a focus on biomechanics, has been involved in topics relating to clinical research for more than ten years. Dr. Markus Kraft, responsible for pre-clinical research, studied materials sciences at the ETH Zurich and took his PhD in the eld of polymer physics. He has over 20 years of professional experience, of which ten were in the eld of medical engineering. Clinical research Clinical research at CAMLOG is intent on testing own products scienti cally for safety and ef cacy in compliance with high standards. Other objectives include provid- ing evidence-based proof for all important properties and advantages of the implant systems and to ensure the clinical long- term success of the implants. Depend- ing on the objective of the studies, case documentations, large eld studies or ran- domized, controlled multi-center studies are employed. The studies are conducted worldwide in cooperation with universi- from left to right: Dr. Alex Schär, Françoise Peters, Peter Thommen, Dr. Markus Kraft